{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:07:02Z","timestamp":1780387622671,"version":"3.54.1"},"reference-count":7,"publisher":"Oxford University Press (OUP)","issue":"Supplement_5","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>ADVANCE-ID (ADVancing Clinical Evidence in Infectious Diseases) is a clinical trials network comprising more than 100 hospitals across Asia, with additional research sites planned for Africa, the Middle East, and Latin America. The mission of ADVANCE-ID is to conduct high-quality clinical trials that have a global impact on the management of infection. More than 12 000 patients have been enrolled since 2022 in ADVANCE-ID studies. A key aim of ADVANCE-ID is to create evidence from randomized controlled trials to improve treatment, diagnostics, and prevention strategies of serious infections resulting from antimicrobial-resistant bacterial infections. Alongside this, ADVANCE-ID has a commitment to advocate for access to antibiotics and diagnostics for which evidence exists for their use in low- and middle-income countries.<\/jats:p>","DOI":"10.1093\/cid\/ciag122","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T11:30:07Z","timestamp":1774870207000},"page":"S101-S104","source":"Crossref","is-referenced-by-count":0,"title":["Advancing Clinical Evidence in Infectious Diseases: An Infectious Diseases Clinical Trials Network for Asia, the \u201cAntimicrobial Resistance Hot Zone\u201d"],"prefix":"10.1093","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2079-4437","authenticated-orcid":false,"given":"David L","family":"Paterson","sequence":"first","affiliation":[{"name":"ADVANCE-ID, Saw Swee Hock School of Public Health, National University of Singapore, Singapore ,","place":["SINGAPORE"]},{"name":"Infectious Diseases Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore ,","place":["SINGAPORE"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"2026060203212675400_ciag122-B1","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050","volume":"404","author":"Naghavi","year":"2024","journal-title":"Lancet"},{"key":"2026060203212675400_ciag122-B2","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S1473-3099(24)00158-0","article-title":"Global burden associated with 85 pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"24","author":"IHME Pathogen Core Group","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2026060203212675400_ciag122-B3","doi-asserted-by":"crossref","first-page":"100306","DOI":"10.1016\/j.lansea.2023.100306","article-title":"Response to antimicrobial resistance in South-East Asia Region","volume":"18","author":"Sihombing","year":"2023","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"2026060203212675400_ciag122-B4","doi-asserted-by":"crossref","first-page":"e0002507","DOI":"10.1371\/journal.pgph.0002507","article-title":"Drivers of inappropriate use of antimicrobials in South Asia: a systematic review of qualitative literature","volume":"4","author":"Murray","year":"2024","journal-title":"PLoS Global Public Health"},{"key":"2026060203212675400_ciag122-B5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.12688\/wellcomeopenres.19210.1","article-title":"ACORN (A Clinically-Oriented Antimicrobial Resistance Surveillance Network) II: protocol for case based antimicrobial resistance surveillance","volume":"8","author":"Mo","year":"2023","journal-title":"Wellcome Open Res"},{"key":"2026060203212675400_ciag122-B6","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1093\/cid\/ciac476","article-title":"The Staphylococcus aureus network adaptive platform trial protocol: new tools for an old foe","volume":"75","author":"Tong","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2026060203212675400_ciag122-B7","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.1016\/S1473-3099(20)30791-X","article-title":"Personalised randomised controlled trial designs\u2014a new paradigm to define optimal treatments for carbapenem-resistant organisms","volume":"21","author":"Walker","year":"2021","journal-title":"Lancet Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/Supplement_5\/S101\/68447032\/ciag122.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/Supplement_5\/S101\/68447032\/ciag122.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T07:21:32Z","timestamp":1780384892000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/82\/Supplement_5\/S101\/8699683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":7,"journal-issue":{"issue":"Supplement_5","published-online":{"date-parts":[[2026,6,2]]},"published-print":{"date-parts":[[2026,6,2]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciag122","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6,15]]},"published":{"date-parts":[[2026,6,2]]}}}